UNH Stock Recent News
UNH LATEST HEADLINES
UnitedHealth Group operates through UnitedHealthcare (insurance) and Optum (health services, tech, pharmacy), making it a global healthcare leader. Shares have plummeted over 40% in 2025, reflecting negative sentiment and recent underperformance. Q1 earnings were mixed: some growth areas, but also notable shortfalls and missed targets.
UnitedHealth Group Inc (NYSE: UNH) – the largest US health insurer – is trading at a historically attractive valuation at the time of writing. Despite the apparent bargain, however, famed investor Jim Cramer is urging caution in loading up on UNH shares.
Healthcare CEFs are under pressure from regulatory shifts, but sector defensiveness and discounted valuations can create long-term opportunities. Within the CEF structure, we also have the added benefit that comes with the discount/premium dynamic inherent in the structure. We are looking at two names today that present investors with attractive distributions and that are looking like decently discounted opportunities.
UNH's removal from key Russell growth indices caps a turbulent stretch marked by steep losses, rising costs and regulatory woes.
The Investment Committee give you their top stocks to watch for the second half.
When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments, including Mounjaro, Zepbound, Ozempic, and Wegovy. While these drugs are likely to lead to billions in revenue, Lilly and Novo aren't relying solely on these drugs to grow their businesses.
UnitedHealth: Pivotal Changes Underway
UnitedHealth Group's health services segment, Optum Health, will be led by Patrick Conway, according to an internal company memo.
Key Points in This Article: UnitedHealth Group (UNH) has plummeted nearly 52% from its April peak, driven by a rare series of cataclysmic events.
SAN FRANCISCO , June 26, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises UnitedHealth Group investors that the firm is investigating potential legal claims following revelations that the company is under criminal investigation for fraud and allegedly made false statements to investors. Current shareholders are encouraged to contact the firm.